Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.

2.

Real-life data on Selexipag for the treatment of pulmonary hypertension.

Barnikel M, Kneidinger N, Klenner F, Waelde A, Arnold P, Sonneck T, Behr J, Neurohr C, Milger K.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019832199. doi: 10.1177/2045894019832199.

3.

A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation.

Gottlieb J, Neurohr C, Müller-Quernheim J, Wirtz H, Sill B, Wilkens H, Bessa V, Knosalla C, Porstner M, Capusan C, Strüber M.

Am J Transplant. 2019 Jan 7. doi: 10.1111/ajt.15251. [Epub ahead of print]

PMID:
30615259
4.

[Diagnosis and Treatment of Interstitial Lung Diseases].

Jakubczyc A, Neurohr C.

Dtsch Med Wochenschr. 2018 Dec;143(24):1774-1777. doi: 10.1055/a-0622-9299. Epub 2018 Dec 3. German.

PMID:
30508858
5.

Asthma features in severe COPD: Identifying treatable traits.

Matthes S, Stadler J, Barton J, Leuschner G, Munker D, Arnold P, Villena-Hermoza H, Frankenberger M, Probst P, Koch A, Kneidinger N, Milger K, Behr J, Neurohr C.

Respir Med. 2018 Dec;145:89-94. doi: 10.1016/j.rmed.2018.10.027. Epub 2018 Oct 26.

PMID:
30509722
6.

Endobronchial One-Way Valve Therapy Facilitates Weaning from Extracorporeal Membrane Oxygenation in a Patient with ARDS and Persistent Air Leak.

Ghiani A, Hansen M, Tsitouras K, Neurohr C.

Case Rep Crit Care. 2018 Sep 25;2018:9736217. doi: 10.1155/2018/9736217. eCollection 2018.

7.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
8.

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.

Winkler A, Kahnert K, Behr J, Neurohr C, Kneidinger N, Hatz R, Dressel H, Radtke T, Jörres RA.

Respir Res. 2018 Sep 10;19(1):171. doi: 10.1186/s12931-018-0881-1.

9.

General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Grünig E, Benjamin N, Krüger U, Kaemmerer H, Harutyunova S, Olsson KM, Ulrich S, Gerhardt F, Neurohr C, Sablotzki A, Halank M, Marra AM, Kabitz HJ, Thimm G, Fliegel KG, Klose H.

Int J Cardiol. 2018 Dec 1;272S:30-36. doi: 10.1016/j.ijcard.2018.08.085. Epub 2018 Aug 27.

PMID:
30190156
10.

[What rheumatologists can learn from pneumologists].

Leuschner G, Neurohr C.

Z Rheumatol. 2018 Aug;77(6):477-483. doi: 10.1007/s00393-018-0507-5. Review. German.

PMID:
30006857
11.

Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.

Leuschner G, Reiter F, Stocker F, Crispin A, Kneidinger N, Veit T, Klenner F, Ceelen F, Zimmermann G, Leuchte H, Reu S, Dinkel J, Behr J, Neurohr C.

Lung. 2018 Aug;196(4):401-408. doi: 10.1007/s00408-018-0123-9. Epub 2018 May 14.

PMID:
29761229
12.

Five-year experience using the Lung Allocation Score: the Munich Lung Transplant Group.

Schuba B, Scheklinski M, von Dossow V, Schneider C, Preissler G, Kneidinger N, Neurohr C, Michel S, Hagl C, Schramm R.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):328-333. doi: 10.1093/ejcts/ezy035.

PMID:
29462335
13.

Posaconazole liquid vs tablet formulation in lung transplant recipients.

Stelzer D, Weber A, Ihle F, Matthes S, Ceelen F, Zimmermann G, Kneidinger N, Schramm R, Winter H, Zoller M, Vogeser M, Behr J, Neurohr C.

Mycoses. 2018 Mar;61(3):186-194. doi: 10.1111/myc.12724. Epub 2017 Nov 22.

PMID:
29110351
14.

Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.

Leuschner G, Stocker F, Veit T, Kneidinger N, Winter H, Schramm R, Weig T, Matthes S, Ceelen F, Arnold P, Munker D, Klenner F, Hatz R, Frankenberger M, Behr J, Neurohr C.

J Heart Lung Transplant. 2017 Jul 5. pii: S1053-2498(17)31886-7. doi: 10.1016/j.healun.2017.07.002. [Epub ahead of print]

PMID:
28734935
15.

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J.

Respir Res. 2017 Jul 14;18(1):139. doi: 10.1186/s12931-017-0621-y.

16.

Lung volumes predict survival in patients with chronic lung allograft dysfunction.

Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Königshoff M, Weig T, Schramm R, Winter H, Behr J, Neurohr C.

Eur Respir J. 2017 Apr 12;49(4). pii: 1601315. doi: 10.1183/13993003.01315-2016. Print 2017 Apr.

17.

[Current Developments in Lung Transplantation].

Neurohr C, Ceelen F.

Dtsch Med Wochenschr. 2017 Apr;142(7):517-520. doi: 10.1055/s-0042-122720. Epub 2017 Apr 7. German. No abstract available.

PMID:
28388748
18.

Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.

Stelzer D, Weber A, Ihle F, Matthes S, Ceelen F, Zimmermann G, Kneidinger N, Schramm R, Winter H, Zoller M, Vogeser M, Behr J, Neurohr C.

Ther Drug Monit. 2017 Apr;39(2):93-101. doi: 10.1097/FTD.0000000000000371.

19.

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.

Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23.

20.

An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.

Ruttens D, Verleden SE, Bijnens EM, Winckelmans E, Gottlieb J, Warnecke G, Meloni F, Morosini M, Van Der Bij W, Verschuuren EA, Sommerwerck U, Weinreich G, Kamler M, Roman A, Gomez-Olles S, Berastegui C, Benden C, Holm AM, Iversen M, Schultz HH, Luijk B, Oudijk EJ, Kwakkel-van Erp JM, Jaksch P, Klepetko W, Kneidinger N, Neurohr C, Corris P, Fisher AJ, Lordan J, Meachery G, Piloni D, Vandermeulen E, Bellon H, Hoffmann B, Vienneau D, Hoek G, de Hoogh K, Nemery B, Verleden GM, Vos R, Nawrot TS, Vanaudenaerde BM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600484. doi: 10.1183/13993003.00484-2016. Print 2017 Jan.

21.

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.

Grünig E, Benjamin N, Lange TJ, Krueger U, Klose H, Neurohr C, Wilkens H, Halank M, Seyfarth HJ, Held M, Traube A, Pernow M, Grover ER, Egenlauf B, Gerhardt F, Viethen T, Rosenkranz S.

Respiration. 2016;92(6):362-370. Epub 2016 Oct 27.

22.

[General and supportive therapy of pulmonary arterial hypertension].

Grünig E, Benjamin N, Krüger U, Kaemmerer H, Harutyunova S, Olsson KM, Ulrich S, Gerhardt F, Neurohr C, Sablotzki A, Halank M, Kabitz HJ, Thimm G, Fliegel KG, Klose H.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S26-S32. Epub 2016 Oct 19. Review. German.

PMID:
27760447
23.

Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.

Fernandez IE, Greiffo FR, Frankenberger M, Bandres J, Heinzelmann K, Neurohr C, Hatz R, Hartl D, Behr J, Eickelberg O.

Eur Respir J. 2016 Oct;48(4):1171-1183. doi: 10.1183/13993003.01826-2015. Epub 2016 Sep 1.

24.

Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study.

Konstantinides SV, Barco S, Rosenkranz S, Lankeit M, Held M, Gerhardt F, Bruch L, Ewert R, Faehling M, Freise J, Ghofrani HA, Grünig E, Halank M, Heydenreich N, Hoeper MM, Leuchte HH, Mayer E, Meyer FJ, Neurohr C, Opitz C, Pinto A, Seyfarth HJ, Wachter R, Zäpf B, Wilkens H, Binder H, Wild PS.

J Thromb Thrombolysis. 2016 Nov;42(4):600-9. doi: 10.1007/s11239-016-1415-7.

25.

Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis.

Bonella F, Kreuter M, Hagmeyer L, Neurohr C, Keller C, Kohlhaeufl MJ, Müller-Quernheim J, Milger K, Prasse A; German Nintedanib Compassionate Use Consortium.

Respiration. 2016;92(2):98-106. doi: 10.1159/000448288. Epub 2016 Aug 20.

26.

Suspected pulmonary embolism in patients with pulmonary fibrosis: Discordance between ventilation/perfusion SPECT and CT pulmonary angiography.

Leuschner G, Wenter V, Milger K, Zimmermann GS, Matthes S, Meinel FG, Lehner S, Neurohr C, Behr J, Kneidinger N.

Respirology. 2016 Aug;21(6):1081-7. doi: 10.1111/resp.12797. Epub 2016 Apr 7.

PMID:
27061739
27.

A novel role of MMP-13 for murine DC function: its inhibition dampens T-cell activation.

Bartmann J, Frankenberger M, Neurohr C, Eickelberg O, Noessner E, von Wulffen W.

Int Immunol. 2016 Oct;28(10):473-487. Epub 2016 Feb 26.

PMID:
26921214
28.

Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates.

Weig T, Milger K, Langhans B, Janitza S, Sisic A, Kenn K, Irlbeck T, Pomschar A, Johnson T, Irlbeck M, Behr J, Czerner S, Schramm R, Winter H, Neurohr C, Frey L, Kneidinger N.

Ann Thorac Surg. 2016 Apr;101(4):1318-25. doi: 10.1016/j.athoracsur.2015.10.041. Epub 2016 Jan 12.

PMID:
26794887
29.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.

30.

Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis.

Leuchte HH, Mernitz P, Baezner C, Baumgartner RA, von Wulffen W, Neurohr C, Behr J.

Respiration. 2015;90(6):460-7. doi: 10.1159/000441302. Epub 2015 Nov 27.

31.

Combined Lung and Liver Transplantation With Extracorporeal Membrane Oxygenation Instead of Cardiopulmonary Bypass.

Scheiermann P, Czerner S, Kaspar M, Schramm R, Winter H, Wimmer CD, Guba M, Stangl M, Faltenbacher V, Ripperger M, Frey L, Neurohr C, Behr J, Meiser B, Hagl C, Zwissler B, von Dossow V.

J Cardiothorac Vasc Anesth. 2016 Apr;30(2):437-42. doi: 10.1053/j.jvca.2015.06.034. Epub 2015 Jun 30. No abstract available.

PMID:
26432697
32.

Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

Milger K, Kneidinger N, Neurohr C, Reichenberger F, Behr J.

Eur Respir J. 2015 Oct;46(4):1217-21. doi: 10.1183/13993003.00584-2015. Epub 2015 Sep 4. No abstract available.

33.

The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation.

Hoechter DJ, von Dossow V, Winter H, Müller HH, Meiser B, Neurohr C, Behr J, Guenther S, Hagl C, Schramm R.

Thorac Cardiovasc Surg. 2015 Dec;63(8):706-14. doi: 10.1055/s-0035-1556873. Epub 2015 Aug 20.

PMID:
26291747
34.

[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis].

Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U.

Pneumologie. 2015 Aug;69(8):455-8. doi: 10.1055/s-0034-1392602. Epub 2015 Jul 30. German.

35.

Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.

Kauke T, Kneidinger N, Martin B, Dick A, Schneider C, Schramm R, Meimarakis G, Preissler G, Eickelberg O, von Dossow V, Behr J, Hatz R, Neurohr C, Winter H.

Tissue Antigens. 2015 Sep;86(3):178-85. doi: 10.1111/tan.12626. Epub 2015 Jul 23.

PMID:
26204790
36.

FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.

Staab-Weijnitz CA, Fernandez IE, Knüppel L, Maul J, Heinzelmann K, Juan-Guardela BM, Hennen E, Preissler G, Winter H, Neurohr C, Hatz R, Lindner M, Behr J, Kaminski N, Eickelberg O.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):455-67. doi: 10.1164/rccm.201412-2233OC.

37.

Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.

Leuchte HH, Baezner C, Baumgartner RA, Muehling O, Neurohr C, Behr J.

Heart. 2015 Jun;101(12):972-6. doi: 10.1136/heartjnl-2015-307529.

PMID:
26015441
38.

Changes in the current classification of IIP: A critical review.

Neurohr C, Behr J.

Respirology. 2015 Jul;20(5):699-704. doi: 10.1111/resp.12553. Epub 2015 May 26. Review.

39.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.

40.

An unusual case of primary hepatic lymphoma mimicking sarcoidosis in MRI.

Do TD, Neurohr C, Michl M, Reiser MF, Zech CJ.

Acta Radiol Short Rep. 2014 May 10;3(4):2047981613493625. doi: 10.1177/2047981613493625. eCollection 2014 May.

41.

Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.

Kneidinger N, Giessen C, von Wulffen W, Milger K, Schramm R, Jäger G, Nitschko H, Striebinger H, Behr J, Neurohr C.

Int J Infect Dis. 2014 Nov;28:140-2. doi: 10.1016/j.ijid.2014.06.009. Epub 2014 Sep 26.

42.

Evaluation of Short-Term Outcome after Lung Transplantation in the Lung Allocation Score Era.

Kneidinger N, Holzborn J, Czerner S, Weig T, Behr J, Winter H, Neurohr C, Schramm R.

Thorac Cardiovasc Surg. 2015 Dec;63(8):693-8. doi: 10.1055/s-0034-1387821. Epub 2014 Sep 3.

PMID:
25184610
43.

Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.

Zimmermann GS, von Wulffen W, Huppmann P, Meis T, Ihle F, Geiseler J, Leuchte HH, Tufman A, Behr J, Neurohr C.

Respirology. 2014 Jul;19(5):700-6. doi: 10.1111/resp.12294. Epub 2014 Apr 3.

44.

Munich lung transplant group: waiting list during the first 9 months of the lung allocation score era.

Kneidinger N, Winter H, Sisic A, Preissler G, Neurohr C, Czerner S, Weig T, Dolch M, Uberfuhr P, Schramm R.

Thorac Cardiovasc Surg. 2014 Aug;62(5):422-6. doi: 10.1055/s-0033-1345021. Epub 2013 Dec 19.

PMID:
24356999
45.

Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension.

Meinel FG, Graef A, Thierfelder KM, Armbruster M, Schild C, Neurohr C, Reiser MF, Johnson TR.

Rofo. 2014 Feb;186(2):151-6. doi: 10.1055/s-0033-1350412. Epub 2013 Aug 23.

46.

Parameters associated with short- and midterm survival in bridging to lung transplantation with extracorporeal membrane oxygenation.

Weig T, Irlbeck M, Frey L, Zwißler B, Winter H, Preissler G, Schramm R, Neurohr C, Dolch ME.

Clin Transplant. 2013 Sep-Oct;27(5):E563-70. doi: 10.1111/ctr.12197. Epub 2013 Jul 31.

PMID:
23898897
47.

Effectiveness of automated quantification of pulmonary perfused blood volume using dual-energy CTPA for the severity assessment of acute pulmonary embolism.

Meinel FG, Graef A, Bamberg F, Thieme SF, Schwarz F, Sommer WH, Neurohr C, Kupatt C, Reiser MF, Johnson TR.

Invest Radiol. 2013 Aug;48(8):563-9. doi: 10.1097/RLI.0b013e3182879482.

PMID:
23519007
48.

Pirfenidone: a potential therapy for progressive lung allograft dysfunction?

Ihle F, von Wulffen W, Neurohr C.

J Heart Lung Transplant. 2013 May;32(5):574-5. doi: 10.1016/j.healun.2013.02.004. Epub 2013 Feb 28. No abstract available.

PMID:
23453574
49.

[German guideline for diagnosis and management of idiopathic pulmonary fibrosis].

Behr J, Günther A, Ammenwerth W, Bittmann I, Bonnet R, Buhl R, Eickelberg O, Ewert R, Gläser S, Gottlieb J, Grohé C, Kreuter M, Kroegel C, Markart P, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Sitter H, Theegarten D, Theile A, Wilke A, Wirtz H, Witt C, Worth H, Zabel P, Müller-Quernheim J, Costabel U.

Pneumologie. 2013 Feb;67(2):81-111. doi: 10.1055/s-0032-1326009. Epub 2013 Jan 16. German.

50.

Assessing pulmonary perfusion in emphysema: automated quantification of perfused blood volume in dual-energy CTPA.

Meinel FG, Graef A, Thieme SF, Bamberg F, Schwarz F, Sommer WH, Helck AD, Neurohr C, Reiser MF, Johnson TR.

Invest Radiol. 2013 Feb;48(2):79-85. doi: 10.1097/RLI.0b013e3182778f07.

PMID:
23288014

Supplemental Content

Loading ...
Support Center